Boston Scientific falls as cyberattack seen hurting 2026 sales, profit

** Medical device maker Boston Scientific's BSX.N shares fall 2.6% to $46.55 premarket

** The company is unlikely to meet net sales growth and adjusted EPS forecasts for the third quarter and FY26

** BSX says a cybersecurity attack is causing global operational disruptions

** The investigation is on; no evidence of ongoing unauthorized access — Boston Scientific

** BSX reported the incident that disrupted operations, including information systems used to process and ship customer orders, on August 26; it was detected on August 25

** As of last close, the stock has nearly halved YTD